BTG Visual-ICE - Indications; Contraindications

1-4 User Manual
1.4 Indications
The Visual-ICE Cryoablation System is indicated for use as a cryosurgical tool in the elds of general
surgery, dermatology, neurology (including cryoanalgesia), thoracic surgery (with the exception of
cardiac tissue), ENT, gynecology, oncology, proctology, and urology. This system is designed to
destroy tissue (including prostate and kidney tissue, liver metastases, tumors, and skin lesions) by
the application of extremely cold temperatures.
The Visual-ICE Cryoablation System has the following specic indications:
• Urology Ablation of prostate tissue in cases of prostate cancer
and Benign Prostate Hyperplasia (BPH)
• Oncology Ablation of cancerous or malignant tissue and benign
tumors, and palliative intervention
• Dermatology Ablation or freezing of skin cancers and other cutaneous
disorders
Destruction of warts or lesions, angiomas, sebaceous
hyperplasia, basal cell tumors of the eyelid or canthus
area, ulcerated basal cell tumors, dermatobromas, small
hemangiomas, mucocele cysts, multiple warts, plantar
warts, actinic and seborrheic keratosis, cavernous
hemangiomas, peri-anal condylomata, and palliation of
tumors of the skin
• Gynecology Ablation of malignant neoplasia or benign dysplasia of
the female genitalia
• General surgery Palliation of tumors of the rectum, hemorroids, anal
ssures, pilonidal cysts, and recurrent cancerous lesions,
ablation of breast broadenomas
• ENT Palliation of tumors of the oral cavity and ablation of
leukoplakia of the mouth
• Thoracic surgery (with the exception of cardiac tissue)
• Proctology Ablation of benign or malignant growths of the anus or
rectum, and hemorroids
1.5 Contraindications
There are no known contraindications specic to the use of the Galil Medical Visual-ICE Cryoablation
System.